Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Plunges 5%; BSE HEALTHCARE Index Down 0.5%
Mon, 9 Sep 14:16

INDRAPRASTHA MEDICAL Plunges 5%; BSE HEALTHCARE Index Down 0.5%Image source: peterschreiber.media/www.istockphoto.com

INDRAPRASTHA MEDICAL share price has plunged 5% and is presently trading at Rs 446.9.

Meanwhile, the BSE HEALTHCARE index is at 43,262.6 (down 0.5%).

Among the top losers in the BSE HEALTHCARE index today are MAX HEALTHCARE INSTITUTE (down 2.8%) and GRANULES INDIA (down 2.7%).

Jubilant Pharmova (up 8.9%) and HIKAL CHEMIC (up 7.5%) are among the top gainers today.

Over the last one year, INDRAPRASTHA MEDICAL has moved up from Rs 171.3 to Rs 446.9, registering a gain of Rs 275.6 (up 160.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,163.1 to 43,262.6, registering a gain of 53.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 133.4%), Jubilant Pharmova (up 124.0%) and GRANULES INDIA (up 114.9%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,392.8 (up 0.3%).

The top gainers among the BSE Sensex today are Hindustan Unilever (up 3.0%) and ITC (up 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.

In the meantime, NSE Nifty is at 24,893.5 (up 0.2%). Hindustan Unilever and ITC are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,780.3 to 81,392.8, registering a gain of 15,612.5 points (up 23.7%).

INDRAPRASTHA MEDICAL Financial Update...

INDRAPRASTHA MEDICAL net profit grew 46.8% YoY to Rs 448 million for the quarter ended June 2024, compared to a profit of Rs 305 million a year ago. Net sales rose 13.5% to Rs 3,479 million during the period as against Rs 3,065 million in April-June 2023.

For the year ended March 2023, INDRAPRASTHA MEDICAL reported 47.0% increase in net profit to Rs 862 million compared to net profit of Rs 586 million during FY22. Revenue of the company grew 23.7% to Rs 10,987 million during FY23.

The current Price to earnings ratio of INDRAPRASTHA MEDICAL, based on rolling 12 month earnings, stands at 29.6.


Equitymaster requests your view! Post a comment on "INDRAPRASTHA MEDICAL Plunges 5%; BSE HEALTHCARE Index Down 0.5%". Click here!